
Ovulation Test Kits
Allegations: Falsely advertising the accuracy of ovulation test kits
In February 2020, a class-action lawsuit was filed against Walgreens for allegedly misleadingly marketing Nice! Honey Graham Crackers. Specifically, the complaint claims that the retailer misleadingly represents that the main sweetener in the crackers is honey and the primary flour ingredient is whole grain graham flour when, according to the plaintiffs, the ingredients list shows that sugar is the primary sweetener and the crackers contain more “enriched flour” than “graham flour.” Plaintiffs also allege that the honey in the crackers is used as a coloring ingredient to make them look like they contain more whole grain graham flour than they actually do and the company gives consumers the impression that honey is a flavoring ingredient without adequately disclosing that the crackers also contain other flavoring ingredients. (Brown et al v. Walgreen Co., Case No. 20-cv-891, S.D.N.Y.)
For more of TINA.org’s coverage of the marketing of graham crackers, click here.
Allegations: Falsely advertising the accuracy of ovulation test kits
Allegations: Falsely marketing that products contain no preservatives when they contain preservative ingredients
Allegations: Marketing products as safe without disclosing that they are contaminated with the carcinogen benzene
Allegations: Failing to disclose products contain the carcinogen benzene
Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene
Allegations: Falsely marketing products as recyclable
Allegations: Misleadingly marketing that products are dishwasher safe and heavy duty
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely advertising sunscreens as waterproof
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that medicines relieve sinus pressure and congestion
Allegations: Falsely marketing medicines as treats nasal congestion
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing products as decongestants
Allegations: Falsely marketing medicines as decongestants
Allegations: Falsely marketing that products treat symptoms of pink eye
Allegations: Falsely marketing that medicines treat nasal decongestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing the product as a “treatment” for minor cuts and abrasions without scientific evidence to support such claims
Allegations: Misleadingly marketing products as if they are more suitable for children when they contain the same formulation as the adult version
Allegations: Falsely marketing products as “Non-Drowsy”
Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children
Allegations: Misleadingly marketing pain relieving lidocaine patches
Allegations: Failing to disclose that products may contain a dangerous substance that increases the risk of serious adverse health consequences and death
Allegations: Failing to disclose that products contain a harmful substance and may increase the risk of contracting invasive infections
Allegations: Marketing products as ordinary cigarettes when menthol cigarettes are more dangerous and addictive than other types of cigarettes
Allegations: Misleadingly marketing lidocaine pain relieving patches
Allegations: Misleadingly marketing its infants’ product as specifically formulated for infants and different from its Children’s Pain & Fever Acetaminophen Oral Suspension when both medications contain the same amount and…
Allegations: Misleadingly marketing products as “Maximum Strength” when other products deliver more lidocaine
Allegations: Misleadingly marketing medicines as “non-drowsy” when the active ingredient in them causes drowsiness
Allegations: Falsely marketing products as “fast-release” when they do not work faster than other products marketed as “fast-release”
Allegations: Falsely marketing that the tablets do not contain gelatin when they contain a “notable” amount of gelatin
Several store-brand aloe vera gels lack the acclaimed soothing ingredient.
Final Agreement Bans Deceptive Claims Made by Walmart, Walgreens & Supervalu MADISON, CONN. March 25, 2015 — A federal judge has given final approval to a class-action settlement that permanently changes how…
Federal judge approves revised class-action settlement terms following TINA.org objection to original proposal.
TINA.org, continuing its efforts to oppose unfair settlements, files an objection.
State officials demand Walmart, Target, Walgreens and GNC stop selling the supplements.